demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
secondary prevention
anticoagulant
rivaroxaban MICHELLE

12 studies excluded by filtering options 3

5071 Tang, 2020 1133not a RCThigh risk of bias
5355 Paranjpe, 2020 1134not a RCThigh risk of bias
5404 Tremblay, 2020 1130not a RCTrisk of bias not avaialble
5441 Ayerbe, 2020 1130not a RCTrisk of bias not avaialble
5777 Bousquet, 2020 1130not a RCTrisk of bias not avaialble
5777 Bousquet, 2020 1130not a RCTrisk of bias not avaialble
6283 Lynn, 2020 0130selection pending
6393 Rossi, 2020 1130not a RCTrisk of bias not avaialble
6396 Russo, 2020 1130not a RCTrisk of bias not avaialble
6404 Trinh, 2020 1130not a RCTrisk of bias not avaialble
6406 Gonzalez-Porras, 2020 1130not a RCTrisk of bias not avaialble
6406 Gonzalez-Porras, 2020 1130not a RCTrisk of bias not avaialble